Dr Reddys Laboratories Share Price
CMP as on 19-Jan-21 15:56
₹ 5,088.90Open
₹ 5,088.00Turnover (lac)
₹ 40,614Prev. Close
₹ 5,052.10Day's Vol (shares)
₹ 7,98,099CMP as on19-Jan-21 15:33
₹ 5,083.45Open
₹ 5,075.00Turnover (lac)
₹ 2,203Prev. Close
₹ 5,052.80Day's Vol (shares)
₹ 21,933CMP as on 19-Jan-21 0:00
₹ 5,108.30Open
₹ 5,085.30Open Interest(Contracts)
₹ 27,82,500VWAP
₹ 5,090.69Day's Vol (shares)
₹ 7,42,625News
-
DCGI approves Dr Reddy's phase 3 clinical trial for the Sputnik V vaccine in Ind
15:02 IST, Jan 18The phase will be conducted on 1500 subjects as part of the randomized, double-blind, parallel-group, placebo-controlled study in India
-
Nifty Pharma sheds 220 pts amid Covid-19 vaccine rollout as heavyweights Sun Pha
14:14 IST, Jan 18The index has dipped to an intraday low of 12,592.80. All stocks listed on Nifty Pharma were trading in the red.
-
Dr. Reddys receives DCGI approval to conduct Phase 3 clinical trial for Sputnik
12:56 IST, Jan 16Dr. Reddys receives DCGI approval to conduct Phase 3 clinical trial for Sputnik V vaccine in India
-
Dr Reddys Lab gets DCGI nod for Phase 3 COVID vaccine trial
9:58 IST, Jan 16The drug major on Friday said that it received an approval from the Drugs Control General of India (DCGI) to conduct phase 3 clinical t
-
Dr Reddy's seeks DCGIs approval to continue phase 3 clinical trials of Sputnik V
12:05 IST, Jan 12Dr Reddys and Russian Direct Investment Fund (RDIF) entered into a partnership in September last year, to conduct the clinical trials o
-
Dr. Reddys Laboratories launches Febuxostat Tablets in U.S. market
17:19 IST, Jan 11Dr. Reddys Laboratories launches Febuxostat Tablets in U.S. market
-
Dr Reddy's Lab launches Febuxostat Tablets in the US market
16:17 IST, Jan 11The company's Febuxostat Tablets are available in 40 mg and 80 mg strengths in bottle count sizes of 30 tablets.
-
Dr. Reddys Labs rises on launching febuxostat tablets in US
14:48 IST, Jan 11Dr. Reddys Laboratories gained 1.3% to Rs 5406.70 after the drug major announced the launch of febuxostat tablets in the US market.
-
Dr Reddys Laboratories to announce Q3 results on 29 Jan
16:26 IST, Jan 08Dr Reddys Laboratories to announce Q3 results on 29 Jan
-
Dr Reddys Laboratories Ltd soars 0.77%, rises for fifth straight session
13:00 IST, Jan 05Dr Reddys Laboratories Ltd is quoting at Rs 5313, up 0.77% on the day as on 12:44 IST on the NSE. The stock is up 84.55% in last one ye
